Authors:
Weinehall, L
Hellsten, G
Boman, K
Hallmans, G
Citation: L. Weinehall et al., Prevention of cardiovascular disease in Sweden: The Norsjo community intervention programme - Motives, methods and intervention components, SCAND J P H, 2001, pp. 13-20
Authors:
Weinehall, L
Hellsten, G
Boman, K
Hallmans, G
Asplund, K
Wall, S
Citation: L. Weinehall et al., Can a sustainable community intervention reduce the health gap? 10-Year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease, SCAND J P H, 2001, pp. 59-68
Authors:
Thogersen, AM
Nilsson, TK
Dahlen, G
Jansson, JH
Boman, K
Huhtasaari, F
Hallmans, G
Citation: Am. Thogersen et al., Homozygosity for the C-677 -> T mutation of 5,10-methylenetetrahydrofolatereductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden, CORON ART D, 12(2), 2001, pp. 85-90
Authors:
Devereux, RB
Bella, J
Boman, K
Gerdts, E
Nieminen, MS
Rokkedal, J
Papademetriou, V
Wachtell, K
Wright, J
Paranicas, M
Okin, PM
Roman, MJ
Smith, G
Dahlof, B
Citation: Rb. Devereux et al., Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study, BLOOD PRESS, 10(2), 2001, pp. 74-82
Authors:
Ohgren, B
Weinehall, L
Stegmayr, B
Boman, K
Hallmans, G
Wall, S
Citation: B. Ohgren et al., What else adds to hypertension in predicting stroke? An incident case-referent study, J INTERN M, 248(6), 2000, pp. 475-482
Citation: K. Boman et G. Bodegard, Long-term coping in childhood cancer survivors: influence of illness, treatment and demographic background factors, ACT PAEDIAT, 89(1), 2000, pp. 105-111
Authors:
Devereux, RB
Roman, MJ
Palmieri, V
Okin, PM
Boman, K
Gerdts, E
Nieminen, MS
Papademetriou, V
Wachtell, K
Dahlof, B
Citation: Rb. Devereux et al., Left ventricular wall stresses and wall stress-mass-heart rate products inhypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study, J HYPERTENS, 18(8), 2000, pp. 1129-1138
Authors:
Johansson, L
Jansson, JH
Boman, K
Nilsson, TK
Stegmayr, B
Hallmans, G
Citation: L. Johansson et al., Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke, STROKE, 31(1), 2000, pp. 26-32
Authors:
Lindholm, L
Hallgren, CG
Boman, K
Markgren, K
Weinehall, L
Ogren, JE
Citation: L. Lindholm et al., Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease?, HEALTH POLI, 48(3), 1999, pp. 155-170
Authors:
Dahmoun, M
Boman, K
Cajander, S
Westin, P
Backstrom, T
Citation: M. Dahmoun et al., Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase, J CLIN END, 84(5), 1999, pp. 1737-1743
Authors:
Trope, C
Hogberg, T
Kaern, J
Bertelsen, K
Bjorkholm, E
Boman, K
Himmelmann, A
Horvath, G
Jacobsen, A
Kuoppola, T
Vartianen, J
Lund, B
Onsrud, M
Puistola, U
Salmi, T
Scheistroen, M
Sandvei, R
Simonsen, E
Sorbe, B
Tholander, B
Westberg, R
Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307